Uncategorized

Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership

Published

2 weeks ago

on

April 23, 2026

By

Temp User

The takeover will give Amneal control of four facilities to manufacture biosimilars for a planned wave of launches in the coming years.

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

The old and New Edition cast comes together to perform

Exit mobile version